IGF1R and diabetes mellitus: Blocking Igf1r in β-cells can mitigate aging-induced β-cell senescence and dysfunction, which contribute to a diabetes-related decline in β-cell function (Iwasaki et al., 2023; Perez-Matute et al., 2022).